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Efficient gene transfer with extended gene expression 
is essential for successful treatment of skin diseases 
using gene therapy. Previously we evaluated a phys-
ical gene transfer method (gene gun delivery) for its 
ability to transfect the epidermis ill llivo. In this study, 
we tested two viral vectors for their ability to trans-
duce murine epidermis through topical application. 
Both an adenoviral vector and a herpes simplex virus 
(HSV) amplicon vector transduced murine epidermis 
with high efficiency after topical application. Differ-
ences in amount and duration of trans gene expres-
sion were conlpared between these two vectors. 
Quantitative analysis of reporter IneZ gene expression 
E fti cient gene transfer to epider1l1a~ keratinocytes is. the fou ndation for gene therapy of epidermal diseases such as epidermol ysis bullosa simplex . epidermolytic hyper-keratosis. and lamellar ichthyosis. Because the skin is an accessible organ. it is an ideal model to test novel 
vectors and delivery systems. Gene transfer procedures are available 
for transfection of keratinocytes in culture (Fenjves, 1994) , which 
are u sed for ex lIillO gene therapy procedures Oensen et 111. 1994; 
Krueger et 11/, 1994). Techniques for ill lIillo gene transfer in to the 
epidermis include direct injection of naked DNA (Hengge et 111, 
1995), gene-gun delivery of plasmid DNA, as well as subcutaneous 
injection of adenoviral vectors (Lu el 111, 1996) . Viral vectors have 
become a desirable tool in the field of gene therapy because of their 
capaciry for efficient gene transfer Oolly, 1994). Adenovirus is a 
very popular vector because it has a broad host range and is abl e to 
infect nondividin g cells; it is also relati vely easy to make a 
recornbi.nant adenovirus containing a gene of interest and to harves t 
high-titer vim I preparations (Kozarsky and Wilso n. 1993). Herpes 
sinlplex virus type-I (I-ISV-l), a DNA virus, normally es tablishes 
latency in peripheral sensory ga nglia followin g primary infection of 
skin (Hill , 198,ii ). R ecently, defective amp Ii con and recombinant 
HSV vectors have been developed for the purpose of gene therapy 
(Pepo se and Leib, 1994). Although HSV vectors ha ve been tested 
fo r gene transfer to various tissues (Fink et 111, 1992; During et 11/, 
1994; Fong ct 11/, 1995; Mesri el 11/.1995), there is no report of using 
HSV vectors for epidermal gene transfer. 
In a previou s report, we examined the ability of an adenoviral 
vector containing the lu ciferase reporter gene to infect murine 
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showed that the viral vector-mediated gene transfers 
were superior to gene-gun delivery of plasmid DNA. 
Significant necrosis and cytotoxicity, however, were 
observed in the HSV-treated skin. In addition, we 
show that murine epidermis developed hyperkerato-
sis and acanthosis 4 d after an adenoviral vector 
containing a human TGF-a expression unit was ap-
plied topically. Finally we demonstrate the feasibility 
of transduction of fetal skin ill "tel'o by intra amniotic 
injection of an adenovirus vector. Key /vOI·ds: ndelloIJi-
I'IIs/1ICI'pesIJil'lls/skill/ tmllsd"etioll. ] Illvest Del'lllatol 108: 
803-808, 1997 
epidermis followin g subcutaneous injection (Lu et 111. 1996). De-
spite strong expression of th e u'ansgene in dermal cells, only a small 
portion of epidermal cells w ere transduced . limiting the usefulness 
of this approa ch fo r gene delivery to the epidermal compartment. 
H ere we report the results of studies in which topical application of 
adenoviral and HSV vectors were tested for their abili ty to trans-
duce murine skin ill vivo. W e directly compared tlle amount and 
duration of trans gene expression and cytotoxicity between the two 
vectors follo w ing topical application to murine skin. We also 
determined whether biologic effects ofTGF-a on the epiderm.is can 
be indu ced by topical application of an adenoviral vector expressing 
the human TGF-a gene product. Finally, we explored the potential 
usefuln ess of the adenoviral vector for transdu ction of fetal skin ill 
ll tero. These studies are a collection of observations on the useful -
ness of these vectors for gene transfer ill vi llo and ill Ilitro and 
represent an important first step in the exploration of the potential 
application of these vectors in treatment of cutaneous disease. 
While additional studies are required to fu lly examine these 
observations. our results strongly suggest that these vectors may 
have potential use as topical agents for gene delivery to the skin. 
MA TERlALS AND METHODS 
Plasm ids and Viral Vectors The pCMV .laeZ plasmid was obta ined 
from C lonctech (Palo Alto. C Al. The pCMV.lacZ construct uses the 
immediate early C MV gen e promotor/ enhancer. and an intron and poly-
adcnylation signal from SV40. The pHSVlac plasmid is under the transcrip-
tional control of the HSV immediatc / carly promotor and also has a 
polyadenylati on sign al liom SV40 (Gell er and Breakcfield. 1988: FederofF. 
1994) Ad. C MV .lacZ, provided by Dr. David T. C uriel (Unive rsity of 
AlabanHl at Binninghatn) . is an adenoviral vector that contains the nuclea r 
localizing signal of th e SV40 T-andgcn and uses a cytom cga lovi rus (CMV) 
prom oter to drive the Escilericilia w li laeZ gene. A recombinant adeno\' iral 
vector containing a TGF-a expression unit (Ad.RSV.TGF- a) was made by 
cloning a 600-bp X iloll C lal fi:agmcnt containing TGF-a eD N A into the 
Sall /Clal site of the plasmid pADL.1 / R SV(Chen ('( II I, 1994). T he expres-
sion of TGF-a cDNA in thc resulting I'I:lSIllid (pADLlIR SV.TGF-a) is 
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Linder the tl';1 llScriptiona l control of the R Olls s" rcOl11 a virlls (ItS V) long 
termill al repeat. Ad. RSV.TG F-ex was generated by cotransfection of 
pADL. I / R SV-TGF- ex and pJM1 7 (a plasmid containing the comp lete 
adenovirus genome) into the 293 transfo rmed hUlll an kidney cell line 
(ATCC . R ockvill e, MD). Recombinant virus was iso l"tcd frolll a single 
plaq ue, expanded in the 293 ce ll lill e, "nd purified by cesillm gradient 
u ltr<1 ccntrifug::I(:;on (Gra hml1 illld Prcvcc, 199 1. ). V jrus titer was dcten1,illcd 
by optical abso rban ce at 260 ,1111 . H SVhr c is a HSV-l ;lmplieon viral vector 
that contains ti, e laeZ reporter gene . It was made by packaging the plasmid 
(pHSVbc) into HSV-1 particles, lIsing a modifi ed deletion nllltant packag-
ing systelll (Geller el 01, 1990; Federoff, ill press). T ir e vi rus was furthe r 
purifIed and concentrated 5- to 10-fo ld as described (Fede roff ci ai, '1992). 
Vira l tite rs were detefl n iJl ed by expression assays using 3T3 fibroblasts as 
previously described (Fede roff 1'1 aI, 1992). 
Animals and Topical and Intrauterine Gene Transfer Nonprc);"""t 
" lid rimed preg nant C D-I mice wcre purchased fi:o lll C harl es I\..ivcr 
Breeding Labo rato ri es (Wi lmillgton, MA) . Mice were anc,thetizcd with 
ketal11inc (50 lng/ kg) and xylazine (1 0 mg/kg), and hair was removed by a 
comme rcia l dep ila tory (Nair). Seventy percen t ethanol was used to clean 
the area, which was tben tape-stripped three to fo ur times. All Eppendorf lid 
(approximately 8 rnm ill d iameter) was chell immedia tely scaled to the skin 
by SlIpergluc. Viru ses we re diluted in " fi nal volul11e of2 00,u.1 o f ph 0' ph ate 
buffered saline (PBS) and injected in co tir e lid using a 21-gilllge needle. T he 
duration of viral exposure to the skin ranged fi'olll 24 h to a maximum of 
2 d. Cells in cul ture arc transd ll ced wi thin 20 Illin by H SV. and in organotypic 
culture, gene transfer occurs within 6 It; therefore, it is likely that Illost viral 
O'<ll1SdllCeion of murine epidermis occurred within the fi rst 6 h after "pplicatiol1 
ofvin" (CasslIccia-l3oJl l1 efll of ai, '1993). T he procedure lor gene-gun delivery 
of pl;rslllid DNA has been described previously (Lu ci ai, 1996). Intraamniotic 
injectio ll of adenovirus ioto pregnant CD- l nuce in volves techn iqu es o f;lI lItero 
manipu lation of ti,e 1II0 use embryo, which are described by P"paio,"UloU 
(1990). The virus was diluted ill PBS ;rlld 10- 50 ,u.l were injected into the 
allln.iotic cav ities of pregnant mice using it 33- gauge needle. 
Quantitation of fl-Galactosida .• e Activity T ,." nsdu ccd 0,. tr,, " sfected 
ski llS were excised and washed twice in PBS and minced in liquid nitrogen. 
Protein ex tracts we re made by incubating the mi nced ski ll in lys is bune r for 
10 min at r00l11 rC llIpcraturc and were assayed fo r galactosidase acti vity 
using Ga lacto-Light Plus !cit (Tropi" , Bedford, MA) . T he enzyme activity 
was expressed ill en zyme reaction lInits by comparison with the activ ity of 
purified enzyme (Sigma C hemica l Co., St. Lo uis, MO). 
Histolo gic Analyses and i" Situ Detection of {:I-Galactosidase Ac-
tivity SKill biopsies . cultured cells. or mOuse embryos were wa~h ed tw ice 
ill PBS and tixed with 2%, p;mlfonmrldchyde , 0 .2'V. glu tara ldehyde, 0:1%, 
sod ium deox),ebolate, and 0 .07% NP-40 detergent at 4°C for 2 h . T hey 
wet'e thell rinsed ill PBS twi ce and sta ined with X-gal containing solu tio n 
(100 111M sodiwn phospha te (p H 7.3 1), 1.3 111M MgCI" ::\ mM KJFe(CN)o' 
I rng per 1111 X-ga l ill N-N-dill1c tll yl [oJ'l narnidc):lt 37° for 8-16 h . After 
stllining, tissues we re rin sed rwicc ill 3% dimeth yl sulfoxide in PBS, fi xed 
overnight in 10°11, ne utral buffered fo rmalin, embedded ill pa raffi n, and 
processed for 1";l11ato"y lin and eO$in (1-1 & E) staining. 
RES ULTS 
Adcnoviral V c ctors Transduce Murine Skin with High Ef-
ficiency In order to provide suff:icient tim e for viral vectors to 
tran sduce the epidermis topica ll y, we utili zed . an occl usive tech-
niqu e to maintain contact between virus-containing solutions and 
the skin . T he ama to be treated "'<15 fi rst tape-stripped sevel'al times 
to rem ove the corni fied layers and to expose epide rmal cells fo r 
viral transduction . W e found that in the absence of tape stripping, 
little or no transgenc expression was o bserved, even after ex tended 
contact of virus (up to 2 d) with th e epidermis (data not shown) . A 
lid h:ol11 an Eppendorf tube was then affixed to th e 'skin using 
Superglue. A tota l volume of200 ILl of viral solu tion was injected 
into the lid. whi ch covered an area of approximate ly 1 C1112 . Various 
d ilu tions of a cesium g radient-purifi ed Ad.CM V ,IneZ viral stock, 
w hich co ntain J 0 ' 2 viral particl es ill 1 )11) PBS with 3% sucrose , 
were tested for top ical transduction of mlH~ne skin. After 24-48 h 
of viral exposure, we found that 4 X 10 II) particles gave the most 
tran sdu ction w ith the least inA am m ation of tissue. Shorter 
exposures (2-3 h) oftb e virus to th e skin gave essen tiall y simibr 
res ults . App li c,ltio n of 4 X 109 particles did not res ult in 
epiderm al tran sdu ction (da ta not shown). After topi ca l appli ca-
tion of Ad .CMV .lneZ for 48 h , fo llowed by X -gal staini ng, the 
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Figure 1. Transduction of murine epidermis by topical application 
of an adcl10viral vector (Ad,CMV.lncZ). Viral particles (4 X 10 ' '') were 
co pic:rll y applied to mouse s!cin . Two days later. the treated area (l crn2 ) was 
excised for X- ga l sra ill ing. Norc the cells stained blue within the treated are. 
(a. an cfl jilre vicw; swle bar, 15U Ji.m). SlIbscqucrrtJ),. the stailled sample was 
processed for histo logic: e""millati on. T he epidermis including some hair 
fo llicles was ex tensive ly transduced by the virus (IJ and c: sC(l le bar, 20 1-'111 H 
& E). Occasional basal cells we rc transduced by the virus (~) . Note all 
associated in fi ltrate of lymphocytes and neutrophils (r). 
entire slir face of the treated ski n ex hibited strong blu e scallllllg 
(Fig 1(/) . Hi stologic examination of sections of this ti ssue 
sho wed that ke ratin ocytes of th e entire epidermi s expressed uw 
reporte r ge ne (Fig 11,) ; so m e follicular cells also showed trallS-
gene expression (Fig 1e) . An inflam matory innlcrate of mo no-
nucl ear ce ll s and occasional neu trop hils was o bserved closely 
appos ed to the epidermi s, but it \V,IS mild . 
Ad.RSV. TGF-Q Induces Epidermal Acanthosis and Hyper-
keratosis ill Murine Skin In a previous rep ort, we obsen 'ed 
epidermal hyperke ratosis aud h),pergranul osis in murine skin bOIll-
barded by gene gun with a p lasmid that e xpressed human TGF-(\'. 
To dete(J11ine whether topical applica tion of an adenoviral vector 
exp(ess ing TG F-a wou ld res ult in th e sa m e ph e notyp ic chan ges, 
a recombinant viru s (Ad .R SV.TGF- a ) containin g th e human 
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TGF- a expressio n unit was ge nera ted and topically appli ed to 
murine skin fo r 2 d . H yperkera tosis and aca n thosis were ob-
served 4 d la ter in ski ns treated topically with Ad.RSV.TGF- a 
(Fi g 2a) . In contra st , skin treated with the sa m e am o unt of 
contro l vector (Ad.C MV.laz Z) failed to pro du ce a similar 
phenotype, although laeZ transgene product was detected in all 
epidermal layers includin g the ba sa l layer (Fig 2b) . 
HSV Amplicon Virus Transduces Murine Skin, but Results 
in Cytotoxicity To determine whether the H SV amplicon virus 
could transduce murine skin ill II i I/o fo ll owing topical application , a 
purified preparation (5 X 10.1 viral particles ill 200 ILl PBS) was 
applied topica Ll y and held under occl usion overnight, followed by 
staining of treated skin for {3-galactosidase expression . As in results 
with the adenoviral vector (Ad.CMV.laeZ), the entire surface of the 
HSVlac-treated area showed strong blue staining, indi cating a high 
efficiency of transduction (Fig 3(,) . His to logic examination of the 
tissue, however, (Fig 3b) revea led substantial necrosis and inflam-
mation of the treated skin. [n fact, the majority of the {3-galactosi-
dase reaction produ ct was present in what appeared to be necrotic 
epidermal cells, with few if allY viable {3-galaccosidase-expressing 
keratinocytes observed . In order to exclude the possibility that 
these side effects were caused by the length of vira l exposure co the 
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Figure 2. Hyperkeratosis and acan thosis 
induced b y topical a pplication of al1 ad-
cl10 viral vector expressing hUl11.an TGF- a. 
Vira l particles (4 X 10"1) of Ad.RSV.TG F-CI' 
were topi cally appLied ro Illouse skill (11 = J). 
FOllr days late r, treated are as ('I crn 2 ) w e re 
removed and processed fo r histo logic examina-
tion . High-power photomicrograph show ing 
epidermal acallthosis alld hyperkeratosis (II: scllie 
bill', 20 fJ.m ; H & E). [11 comparison , 4 X 10'" 
viral particles of Ad.CMV.lneZ (control) were 
topi ca ll y app l;ed to mouse skin. Four da ys later, 
treated areas (1 crn -) -we re rern o ved , stained by 
X -gal. alld processed for hi stologi exa minatio n. 
N ote cell s in all epidennal layers expressing IneZ 
gene product (b: sCll le bill', 20 pm. H & E). 
skin under occlusion , we exposed murine skin to the HSVla c v.irus 
for only 2 h and coll ected the treated area for histologic analys is. 
Examination of ti ssue sections revealed a similar degree of necrosis 
and inflammation despite the short duration of viral exposure (data 
not shown). 
Comparison of Ad.CMV.lacZ and HSVlac Reporter Gene 
Expression and Duration T he duration and amount of reporter 
gene expression of the two viral vectors (Ad.CMV./acZ and 
HSVlac) were determined by quantitative assessment of {3-galacto-
sidase activi ty. Murine skin (n = 3) was treated top icall y with 
eith er Ad .CMV .lacZ (4 X 10 / 0 panicles) or HSVlac (5 X 104 
particles) , an d th e treated skin wa s biopsi ed after 2, 4, 7. and 
10 d . {3- Galactos id ase activ ity wa s determin ed using protein 
extra cts fro l11 the biopsi es. As shown in Fig 4. skin treated with 
Ad .CMV .lacZ showed high {3- galactos id ase activity that per-
sisted for 7 d, with little or no expression at 10 d. S.kin tr eated 
with HSVla c showe d hig h {3- galactosidase activity initi ally but 
was essentially negativ e after 7 d. W e next compared the 
efri ciency of gene- g un deli very of plasmid DNA with topical 
app li cation of the two viral vec tors (Fig 5). Plasmid DNA 
(pCM V. /aeZ, or pHSVlac) wa s coated onto gold beads and 
bo mbarded o n to m Oll se skin. The operating parameters ll sed 
Figure 3. Transduction ofthc epidermis by topical application ofHSV amplicon , ' ector (HSVlac). Viml particles (5 X 10") were topically appli ed 
[0 mouse skin. Two da ys later , treated areas (1 cm ' ) were excised for X- gal staining. N ote the cells sta ined b lue within the treated area (II. all Cll f llcl' view ; 
scale bar, 150 fJ.m). Subsequently, the sta ined samples wC re processed for hi stO logic exa minatio n . T he epidermis was extensively transdu ced by the virus. 
ahhough signi fica nt nccrosis and cytotox icity we re present (b: scale bil l'. 20 fJ.1ll . H &: E). 
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Figure 4. Extended expression of /3-ga lactosidase activity followin g 
topica l appli cation of adellovir:!l. but no t HSV vec tor s, to murinc sk in. 
Ad .CMV.lncZ (4 X 10'" viral particles) Or H SVio c (5 X 10" viral particles) 
were applied topica ll )' to m Ollse skin (Il = 3). After 2, 4,7. o r 10 d, the 
treated skin sa mples lVe re co ll ected and minced in liquid nitrogen. Protein 
extracts were mad e for dctenninOltion of J3-ga lactos idase activity in th ese 
samples. Each tw' represents the meal! enzyme :lccivi ry in three samplcs ::+:: SEM. 
were based on previous work that established the optima l 
conditions for transfec tion of murine skin using the gene gun (Lu 
e/ aI, 1996) . Biopsies were taken 2 d later, protein was extracted 
as describ ed in i\lIaferials alld Methods, and {3-galactosidase activity 
in each sample was de termined. A t the the 2-d time poine, 
gene-gun delivery of pCMV.lacZ resulted in about 14-fold less 
expression of the reporter gene than did topical application of 
Ad.CMV.laeZ (Fig 5). Similarly, gene-gun delivery ofpHSVlac 
resulte.d in about 40-fold less expression of the laeZ gene at 2 d 
than did topical application of th e amplicon virus (HSV\ac). 
Based on the histologic examination of ampJicon HSV -treated 
skin, whkh exhibited extensive n ecrosis, it is likely that the 
majority of the {3-galactosidase activity present was within 
necrotic cells. 
The greater laeZ expression of the pCMV .laeZ plasnud compared 
with the pHSVlac plasmid following gene-gun delivery suggests 
that the CMV promoter is a stronger' promoter for transgene 
expression in epidermal cells. The pCMV.lacZ and pHSVlac plas-
mid employ virtually identicallaeZ gene segments and SV 40 poly A 
addition sequences, making it unlikely that these contributed to 
differences in J3-galactosidase levels. The 5' -UTRs do differ in the 
two constructs, however, and could result in differences in tran-
script stability, and differences in RNA processing cannot be 
excluded. Although we canllot evaluate the relative effects of 
post- transcriptional processing on the levels of /3-gala ctosidase, it is 
likely that most of the differen ce in J3-galactosidase expression 
observed between tb e two plasl11.ids are due to differences in 
promotor strength. 
Fetal Periderm Is Transduced with High Efficiency by 
lntraamniotic Injection of Adenovirus R ecent advances 
have been made in the diagnosis of genetic disorders of the 
epidermis ill I.aero, such as epidermolysis bullosa (Fine ef aI, 1990) 
and lam ellar ichthyosis (Perry el aI, 1987). Because the genetic 
defects in these diseases have been determin ed (Coulombe cf ai, 
1991; Huber el aI, 199 5), these disorders could potentially lend 
themselves to treatment by correction of tbe defect at the DNA 
level during the prenatal period. In an effort to transduce fetal 
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Figure 5. Compari son of viral-medi ated gene transfer with gene-gun 
deli very of plasmid DNA. Mice (n '" 3) were either topica ll y tre:lted widl 
vin1l veCtors Qr bombarded with gold beads coated with 4 ILg of plasmid 
DNA (pCMV .JncZ or Pl-ISV]" C) . Two days later, the treated skin samples 
were colJ ectcd and l11in ccd ill liquid nitrogen. Protein extra cts were luade 
for determina tio n of /3-ga lactosidase activity. Each ba r represents mean of 
the enzym e activity in three samples ± SEM. 
pulmonary epithelia, McCray et al (1995) observed transgene gene 
expression in feta l epidermis after intraamniotic injection of an 
adenoviral vector. To examine whether this approach is useful for 
the transduction of epidermal stem cells in basal layer, which is 
essential fo r permanent correction of genetic defects , we injected 
the Ad.CMV.laeZ vector (10 10 particles) into the amniotic cavity of 
pregnant CD-1 mice (11 = 3; 15 d post-coition) . Two days later, 
fetuses were harvested and stained for ,B-galactosidase activity. 
Gross eX<lmination of the fetuses showed strong staining over the 
entire surface of th e fetus (Fig 6cr). Histologic examination of the 
transduced fetuses showed that peridermal cells were primarily 
transduced, with li ttle or no transduction of deeper epidermal layers 
(Fig 6b). Neither inflammation nor cytotoxicity was observed. 
DISCUSSION 
In t1us study , we have demonstrated that viral vectors can be used 
to transfer genes of interest into the epidermis with high efficiency 
through topical application. Compared with gene-gun delivery of 
plasmid DNA, topical app lica tion of viral vectors resulted in 
stronger and more persistent transgene expression; however, com-
pared with gene-gun delivery of plasmid DNA, in which little or 00 
inflammation was observed (Lu el aI, 1996), vira l vectors resulted in 
a greater degree of ti ssue inflammation and cytotoxicity, especially 
when the HSV amplicon virus was used. We also demonstrat.ed 
that epiden11<ll changes can be induced by exposing the epidermis to 
an adenovil'a l v ector expressin g the human TGF-a: gene produce, 
showing that expression of the transgene is suffi cient for a biologic 
response using this vector and delivery system. In addition, we 
tes ted the feasibility of gene transfer into fetal epidermis ill IIcero 
through viral transduction . 
Epidermal ge ll.e transfer via eith er gene-gun delivery of plasmid 
DNA (Lu et aI , 1996) or viral vectors is transient with adenoviral 
mediated transfer persisting in th e skin for up to 10 d. The transienc 
nature of tran sgene expression is likely due to the episomal 
loca lization of adenovira l and HSV vectors in the cell as well as 
VOL. 108. NO. MAY 1997 T O PICAL VIR.AL TRA NSDUCT IO N OF EI'IDER.MI S 807 
Figure 6. Fctal peridcrm is transduccd by intraa11111iotic injection ofadcl1ovirus. Particles (lO' U) of Ad.CMV.locZ were illjected into the amlliotic 
sac of pregnant CD-l mice (n = 3; 15-d post- co itioll) . Two days later, fetuses were rcmoved alld stailled by X-ga l. Note the blue stainillg over thc fe tal 
skin (a: senlc bor, 150 um. " indicates the eye; -> indicates the sho ulder). Histologic examination of the stailled fetuses shows man y trall sduced cells in periderm 
(>; bar, 40 !Lm, H & E; b (I", "CI) ; eosill onl y). 
termin al differentiation and elimination of the transdu ced cell s. 
More extended express ion of genes delivered by these viral vectors 
could potentially be achieved if epiden11<11 stem cells could be targeted 
becau se virus would not be eliminated by cell division. Pem1anent 
expression would not be achieved, however, because of the lack of 
integration of these vectors into the host genome. Stem cells are 
label-retaining cells localized in the basal layer of the epidemtis that are 
long-lived and give rise to transient amplifying cells. Although mor-
phologically indistinguishable from non-stem cells in the basal epider-
ntis, certain fea tures, such as increased a2{31 and a3{31 integrin 
eXjJression by stem cell s, may be exploited to target gene expression to 
these cells in the epideL1nis Oones and Watt, 1993; Jones cr ai, 1995). 
In the case of the vectors used in this study, repeated topical application 
of the vector could result in persistent expression of the U':U1sgene. T his 
approach could be usefi.ll for conditions d1at are not clu'onic in nature, 
such as wound healing (Andree c/ ai, 1994) , or for gene-based 
immunization using the skin as a gene-delivery system (Raz er ai, 
1994). Repeated topical application may be limited, however, by 
hun1.oral and cellular immune responses with adenoviral vectors, 
which have been associated with their use (Simon er ai, 1993; Yang el 
ai, 1994; Zabner e/ ai, 1994). Several stra tegies have been proposed to 
eliminate or ameliorate the viral-evoked U1U11une reaction (Yan g e/ ai, 
1994), w hich could potentially u11pLOve expression of d1e trans gene 
through supp.ression of unmune attack on vector-containing cells , and 
limit morbidity associated wid1 inunune reaction to d1e vector. 
Because of the efti cient epidermal transduction by adenoviral 
vectors, other adenovirus-based delivery sys tems may be valuable 
fo r topical gene u'ansfer into the epidermis. For example , adeno-
virus has been coupl ed with polylysine or liposomes (Curiel, 1992; 
Cristiano et ai, 1993; Raja-Walia et nl, 1995) to facilitate the 
entrance of plasmid DNA into m any types of cells in culture. 
Becau se these adenovirus-DNA complexes have the advantage of 
delivering multiple genes of interest without d1e effort of making 
recom.binant viruses, they are potentially useful for topical epider-
mal transfer. Adenovirus has been chemically linked with proteins 
to d e liver genes into target cells (Sed1, 1994) through cell type-
specific receptors that recognize the target protein. Tlus su'ategy 
could be exploited to target epidermal stem cells, which express 
higher levels of {31-integrins compared with non-stem cells in the 
basal epidermal layer. Sunilarly, adenovirus vectors could be chem-
ically linked to melanocyte-stimulating horm one, which would 
selectively target melanocytes, w hich express the melanocyte-
stimulating hormone receptor MC1 but not normal (n011tTanS-
formed) keratinocytes, w luch do not express the MCl receptor. A 
method of gene transfer to the skin w ithou t associated inflamma-
tion is the use of liposomes to selectively target hair foll icle 
keratinocytes (Li and H offinan , 1995). A liposome preparation 
containing the lacZ reporter gene topically applied to mouse skin 
resulted in selective expression of d1e gene in matrical ce ll s of the 
hai r bulb , and possibly to cells of dIe bulge area. The advantage of 
tlus technique over use of adenoviral vectors is the lack of toxiciry 
and the ability to selectively target hair follicle cells, w lu ch could be 
extremely valu able fo r correction of hair follicle-ba sed genetic 
abnormalities. Although tbe duration of protein expression using 
liposome delivery was not stated, it is likely that the adenoviral 
vector system would give longer expression due to persistence of 
the virus in the cell and stronger expression because the entire 
epidermis is transduced and would be useful in situations in which 
selective targeting of the hair follicle epithelilU11 is not required. 
T he am plicon HSV vector exhibited a markedly greater degree 
of cytotoxicity and inflammation when topically appli ed to skin 
compared wi th the adenovira l vector, even after brief appli cations. 
T his m ay be due to d1e expression of residual vira l proteins from the 
amplicon vector sequence o r to wild-type helper viru s in the 
preparation, both of whi ch m ay elicit a cytotoxic host-immune 
response aolly, 1994; Memar e/ ai, 1995). Production ofhelper-fi' ee 
viral preparations and further refl11ement of current HSV vectors by 
eliminating the coding sequence for toxic viral proteins in the 
vector may reduce or elilninate the cytotoxic effects that we 
observed. It is possible that irritation ca used by tape stripping or 
Nair treatment of the skin may have contributed to the u1.flamma-
tory response; therefore, alternative medlOds of weakening epider-
mal barrier, such as low-frequency ultrasound (Mitragotri el nl, 
1995), should be tested for their capacity to enhance viral trans-
duction of the epidermis. 
Because recent advances have been made in the diagnosis of skin 
disease in the prenatal period , it may be possible to correct d1ese 
diseases through delivery of a normal gene to fetal epidermis. 
Theoretically, if the normal gene integrated into the genome of 
epiderm al keratinocytes, correction of the genetic defect could be 
achieved prior to birth. We examined the ability of the adenovil'al 
vector for transduction of fetal skin i/l /I/ero by inj ecting adenovirus 
la eZ constructs into the ammoti c cavity of pregnant mice. We show 
that strong diffuse expression of the transgene occurred over the 
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entire surface of the fetus; histologlc examination tevealed that 
transduction was limited to periderm cells. T he periderm is a 
transient epithelial cell layer that shares biocben"lical and morpho-
logic features with fe ta l amnion (Lane et nl, 1987; Schofi eld e/ nl, 
1990). It is sh ed by da y 18 of fetal m ouse development and at the 
end of the second trimester in human fetal skin development. Its 
fUllction is unknown , but the identification of shared antigens 
between periderm and secret,ll'Y cells, the presence of numerous 
microvilli and blebs, and the association of fetal skin permeability 
and the presence of the periderm strongly suggest an absorptive or 
secretoty function. Because only periderm W 'l S transduced by 
injected virus, it appears unlikely that this technique could be used 
for lon g-term correction of genetic skin diseases. Secretion of 
transgen e products from periderm into tbe amniotic fluid, however, 
may have some potential application for delivery of proteins of 
interest to the amnioti c fluid, whkh could gain access to fetal 
respiratory or intestinal epi thelium. 
In summary, we have shown that viral vectors are effective fo r 
epidermal gene transfer following topkal application. Development 
ofless cytotoxic and immunogenic vectors may be coupled with the 
use of regulatory and gene targeting system s, so that these com-
bined elForts wil1make the conceptual "viral gene cream" a r ea lity 
[or treating geneti c skin disorders. T he demon stration that adeno-
viral vectors can be used to transduce the periderm of a 15-d-old 
fetus ill IIl cro offers the potential for prenata l gene therapy of Skill 
diseases, although long-term correction of feta l epidermal defects 
will require additional studies to devise methods to target fetal 
epidermal stem ceUs with viral vectors c,lpable of stabl e integration 
in to the genome. 
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